Security key
83422E204
Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB)
CUSIP: 83422E204
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 81,357,999
- Total 13F value
- $501,971,186
- Share change
- -912,659
- Put/Call ratio
- 5.8%
- SEC-reported price per share
- $6.17
- Number of holders
- 122
- Value change
- -$1,773,199
- Number of buys
- 61
- Number of sells
- 48
- Shares outstanding
- 92,783,558
Holder snapshot
7 facts
Show 1 more fact
Security identity
1 fact
Report period
Q3 2025
Institutions
122
Top holders
10
SLDB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Solid Biosciences Inc. SEC filings
Solid Biosciences Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 83422E204
Recent filing periods:
Ownership snapshot
Top reported holders of SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Largest current holder
Invus Global Management, LLC
13D/G signal
Invus Global Management, LLC
Evidence rows
15
Latest as of
30 Jun 2025
13D/G
13F
3/4/5
Lead comparable stake: 9.6%
13D/G row: Invus Global Management, LLC
Showing 1-6 of 15 holder rows.
Quick read
Invus Global Management, LLC leads the comparable SEC ownership view at 9.6%.
Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Invus Global Management, LLC
9.6%
BlackRock, Inc.
6.1%
PERCEPTIVE ADVISORS LLC
13%
Bain Capital Life Sciences Invest...
8.5%
Siren, L.L.C.
8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Invus Global Management, LLC |
13D/G
Raymond Debbane
|
9.6%
|
$27,216,371
7,415,905 shares
|
+$13,457,391 | 31 Mar 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
6.1%
from 13D/G
|
$23,960,805
4,920,083 shares
|
— | 30 Jun 2025 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
13%
|
$57,985,366
11,906,646 shares
|
— | 30 Jun 2025 |
| Bain Capital Life Sciences Investors, LLC |
3/4/5
13F
10%+ Owner · Company
|
8.5%
from 13F
|
$46,252,926
11,478,752 shares
mixed-class rows
|
— | 19 Feb 2025 |
| Siren, L.L.C. |
13F
Individual
|
8%
|
$36,115,457
7,415,905 shares
|
— | 30 Jun 2025 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
7.3%
|
$32,772,587
6,729,484 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
122
Shares
81,357,999
Rows available
122
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
110
Q3 2025 holders
122
Holder diff
12
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend